Goodwin Charles D. II 4
4 · Apyx Medical Corp · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Goodwin Charles D. II
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Option to Buy)
2022-01-19+243,000→ 243,000 totalExercise: $10.96From: 2025-01-19Exp: 2032-01-19→ Common Stock (243,000 underlying)
Footnotes (1)
- [F1]Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.